Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Class switch recombination in selective IgA-deficient subjects.

L Hummelshoj1, L P Ryder, L K Nielsen

  • 1Laboratory of Medical Allergology, Allergy Clinic, National University Hospital, Copenhagen, Denmark. l.hummelshoj@rh.dk

Clinical and Experimental Immunology
|June 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pangenome reconstruction of <i>Lactobacillaceae</i> metabolism predicts species-specific metabolic traits.

mSystems·2024
Same author

Suitability of machine learning models for prediction of clinically defined Stage III/IV periodontitis from questionnaires and demographic data in Danish cohorts.

Journal of clinical periodontology·2023
Same author

Impact of Food Matrices on Digestibility of Allergens and Poorly Allergenic Homologs.

Frontiers in allergy·2022
Same author

PET in vivo generators <sup>134</sup>Ce and <sup>140</sup>Nd on an internalizing monoclonal antibody probe.

Scientific reports·2022
Same author

COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.

Cytokine & growth factor reviews·2021
Same author

Microvesicles in active lupus nephritis show Toll-like receptor 9-dependent co-expression of galectin-3 binding protein and double-stranded DNA.

Clinical and experimental immunology·2020

Selective IgA deficiency involves impaired B cell differentiation. Interleukin-4 (IL-4) can restore immunoglobulin A (IgA) production in affected individuals, suggesting a potential therapeutic avenue.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Selective IgA deficiency is a prevalent immunodeficiency in Caucasian populations, yet its underlying molecular mechanisms are not fully understood.
  • Understanding the molecular events governing IgA production is crucial for elucidating the basis of this disorder.

Purpose of the Study:

  • To investigate the molecular basis of selective IgA deficiency by examining B cell differentiation and IgA production.
  • To identify key cytokines and molecular pathways involved in IgA synthesis and B cell maturation in IgA-deficient individuals.

Main Methods:

  • Purification of naive IgD-positive B cells from IgA-deficient and control Caucasian donors.
  • Stimulation of B cells with cytokines (TGF-beta, IFN-gamma, IL-10) and anti-CD40 antibodies to assess activation-induced cytidine deaminase (AID) and alpha germline transcripts (GLT) expression.

Related Experiment Videos

  • Evaluation of B cell differentiation into CD138(+) X-box binding protein 1 (XBP-1)(+) plasma cells and IgA production.

    • Main Results:

    • B cells from IgA-deficient donors exhibited reduced expression of AID and alpha GLT upon stimulation with TGF-beta, IFN-gamma, or IL-10 compared to controls.
    • While IL-10 or IL-10 + TGF-beta could induce some IgA production, it was lower than in controls.
    • IgA-deficient B cells showed impaired differentiation into plasma cells, which was normalized by the addition of IL-4 to TGF-beta or IL-10 + TGF-beta stimulation.

    Conclusions:

    • In healthy individuals, IL-10 enhances IgA production in CD40-stimulated B cells.
    • IgA-deficient subjects display an abnormality in B cell differentiation that is not replicated in healthy controls.
    • Interleukin-4 (IL-4) has the potential to reverse the differentiation defect observed in IgA-deficient B cells, offering a promising therapeutic insight.